1.
Brusamolino E, Passamonti F, Pagnucco G, Castagnola C, Lazzarino M, Bernasconi C. Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma. Haematologica [Internet]. 1998Apr.1 [cited 2026Nov.7];83(4):323-8. Available from: https://haematologica.org/article/view/1087